000852419 001__ 852419
000852419 005__ 20210129235049.0
000852419 0247_ $$2doi$$a10.1016/j.wneu.2018.07.232
000852419 0247_ $$2ISSN$$a1878-8750
000852419 0247_ $$2ISSN$$a1878-8769
000852419 0247_ $$2Handle$$a2128/21805
000852419 0247_ $$2pmid$$apmid:30077752
000852419 0247_ $$2WOS$$aWOS:000447941300079
000852419 037__ $$aFZJ-2018-05373
000852419 082__ $$a610
000852419 1001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b0$$eCorresponding author
000852419 245__ $$aCorrelation of Dynamic O-(2-[18F]Fluoroethyl)-L-Tyrosine Positron Emission Tomography, Conventional Magnetic Resonance Imaging, and Whole-Brain Histopathology in a Pretreated Glioblastoma: A Postmortem Study
000852419 260__ $$aAmsterdam$$bElsevier$$c2018
000852419 3367_ $$2DRIVER$$aarticle
000852419 3367_ $$2DataCite$$aOutput Types/Journal article
000852419 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1541680781_28960
000852419 3367_ $$2BibTeX$$aARTICLE
000852419 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000852419 3367_ $$00$$2EndNote$$aJournal Article
000852419 520__ $$aObjectiveAmino acid positron emission tomography (PET) using O-(2-[18F]fluoroethyl)-L-tyrosine (FET) provides important additional information on the extent of viable tumor tissue of glioblastoma compared with magnetic resonance imaging (MRI). Especially after radiochemotherapy, progression of contrast enhancement in MRI is equivocal and may represent either tumor progression or treatment-related changes. Here, the first case comparing postmortem whole-brain histology of a patient with pretreated glioblastoma with dynamic in vivo FET PET and MRI is presented.MethodsA 61-year-old patient with glioblastoma initially underwent partial tumor resection and died 11 weeks after completion of chemoradiation with concurrent temozolomide. Three days before the patient died, a follow-up FET PET and MRI scan indicated tumor progression. Autopsy was performed 48 hours after death. After formalin fixation, a 7-cm bihemispherical segment of the brain containing the entire tumor mass was cut into 3500 consecutive 20μm coronal sections. Representative sections were stained with hematoxylin and eosin stain, cresyl violet, and glial fibrillary acidic protein immunohistochemistry. An experienced neuropathologist identified areas of dense and diffuse neoplastic infiltration, astrogliosis, and necrosis. In vivo FET PET, MRI datasets, and postmortem histology were co-registered and compared by 3 experienced physicians.ResultsIncreased uptake of FET in the area of equivocal contrast enhancement on MRI correlated very well with dense infiltration by vital tumor cells and showed tracer kinetics typical for malignant gliomas. An area of predominantly reactive astrogliosis showed only moderate uptake of FET and tracer kinetics usually observed in benign lesions.ConclusionsThis case report impressively documents the correct imaging of a progressive glioblastoma by FET PET.
000852419 536__ $$0G:(DE-HGF)POF3-571$$a571 - Connectivity and Activity (POF3-571)$$cPOF3-571$$fPOF III$$x0
000852419 588__ $$aDataset connected to CrossRef
000852419 7001_ $$0P:(DE-HGF)0$$aPiroth, Marc D.$$b1
000852419 7001_ $$0P:(DE-HGF)0$$aSellhaus, Bernd$$b2
000852419 7001_ $$0P:(DE-HGF)0$$aWeis, Joachim$$b3
000852419 7001_ $$0P:(DE-Juel1)131773$$aGeisler, Stefanie$$b4$$ufzj
000852419 7001_ $$0P:(DE-Juel1)131782$$aOros-Peusquens, Ana-Maria$$b5$$ufzj
000852419 7001_ $$0P:(DE-Juel1)131660$$aMohlberg, Hartmut$$b6$$ufzj
000852419 7001_ $$0P:(DE-Juel1)131631$$aAmunts, Katrin$$b7$$ufzj
000852419 7001_ $$0P:(DE-Juel1)131794$$aShah, Nadim J.$$b8$$ufzj
000852419 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b9$$ufzj
000852419 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b10$$ufzj
000852419 773__ $$0PERI:(DE-600)2530041-6$$a10.1016/j.wneu.2018.07.232$$gp. S1878875018317121$$pe653-e660$$tWorld neurosurgery$$v119$$x1878-8750$$y2018
000852419 8564_ $$uhttps://juser.fz-juelich.de/record/852419/files/1ADF51E3.pdf$$yPublished on 2018-08-02. Available in OpenAccess from 2019-08-02.
000852419 8564_ $$uhttps://juser.fz-juelich.de/record/852419/files/1ADF51E3.pdf?subformat=pdfa$$xpdfa$$yPublished on 2018-08-02. Available in OpenAccess from 2019-08-02.
000852419 909CO $$ooai:juser.fz-juelich.de:852419$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b0$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131773$$aForschungszentrum Jülich$$b4$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131782$$aForschungszentrum Jülich$$b5$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131660$$aForschungszentrum Jülich$$b6$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131631$$aForschungszentrum Jülich$$b7$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b8$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b9$$kFZJ
000852419 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b10$$kFZJ
000852419 9131_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x0
000852419 9141_ $$y2018
000852419 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000852419 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000852419 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000852419 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000852419 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bWORLD NEUROSURG : 2015
000852419 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000852419 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000852419 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000852419 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000852419 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000852419 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000852419 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000852419 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000852419 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000852419 9201_ $$0I:(DE-Juel1)INM-1-20090406$$kINM-1$$lStrukturelle und funktionelle Organisation des Gehirns$$x0
000852419 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000852419 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x2
000852419 980__ $$ajournal
000852419 980__ $$aVDB
000852419 980__ $$aUNRESTRICTED
000852419 980__ $$aI:(DE-Juel1)INM-1-20090406
000852419 980__ $$aI:(DE-Juel1)INM-4-20090406
000852419 980__ $$aI:(DE-Juel1)INM-3-20090406
000852419 9801_ $$aFullTexts